Búsqueda | Portal de Búsqueda de la BVS Colombia

1.

Association of Osteopontin, Neopterin, and Myeloperoxidase With Stroke Risk in Patients With Prior Stroke or Transient Ischemic Attacks: Results of an Analysis of 13 Biomarkers From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial.

Ganz, Peter; Amarenco, Pierre; Goldstein, Larry B; Sillesen, Henrik; Bao, Weihang; Preston, Gregory M; Welch, K Michael A.

Stroke ; 48(12): 3223-3231, 2017 12.

Artículo en Inglés | MEDLINE | ID: mdl-29114094

2.

Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial.

Amarenco, Pierre; Callahan, Alfred; Campese, Vito M; Goldstein, Larry B; Hennerici, Michael G; Messig, Michael; Sillesen, Henrik; Welch, K Michael A; Wilson, Daniel J; Zivin, Justin A.

Stroke ; 45(10): 2974-82, 2014 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-25147328

3.

Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial.

Ovbiagele, Bruce; Goldstein, Larry B; Amarenco, Pierre; Messig, Michael; Sillesen, Henrik; Callahan, Alfred; Hennerici, Michael G; Zivin, Justin; Welch, K Michael A.

J Stroke Cerebrovasc Dis ; 23(4): 778-84, 2014 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-24582273

4.

Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

Amarenco, Pierre; Goldstein, Larry B; Sillesen, Henrik; Benavente, Oscar; Zweifler, Richard M; Callahan, Alfred; Hennerici, Michael G; Zivin, Justin A; Welch, K Michael A.

Stroke ; 41(3): 426-30, 2010 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-20110538

5.

Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes.

Amarenco, Pierre; Benavente, Oscar; Goldstein, Larry B; Callahan, Alfred; Sillesen, Henrik; Hennerici, Michael G; Gilbert, Steve; Rudolph, Amy E; Simunovic, Lisa; Zivin, Justin A; Welch, K Michael A.

Stroke ; 40(4): 1405-9, 2009 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-19228842

6.

Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study.

Goldstein, Larry B; Amarenco, Pierre; Lamonte, Marian; Gilbert, Steven; Messig, Michael; Callahan, Alfred; Hennerici, Michael; Sillesen, Henrik; Welch, K Michael A.

Stroke ; 39(9): 2444-8, 2008 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-18617654

7.

Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

Amarenco, Pierre; Goldstein, Larry B; Szarek, Michael; Sillesen, Henrik; Rudolph, Amy E; Callahan, Alfred; Hennerici, Michael; Simunovic, Lisa; Zivin, Justin A; Welch, K Michael A.

Stroke ; 38(12): 3198-204, 2007 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-17962589

8.

Relation between migraine and stroke.

Bousser, Marie-Germaine; Welch, K Michael A.

Lancet Neurol ; 4(9): 533-42, 2005 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-16109360

9.

Ovarian steroids regulate neuropeptides in the trigeminal ganglion.

Puri, Veena; Cui, Lisa; Liverman, Christopher S; Roby, Kathy F; Klein, Robert M; Welch, K Michael A; Berman, Nancy E J.

Neuropeptides ; 39(4): 409-17, 2005 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-15936815

10.

Response of the brain to oligemia: gene expression, c-Fos, and Nrf2 localization.

Liverman, Christopher S; Cui, Lisa; Yong, Chi; Choudhuri, Rajani; Klein, Robert M; Welch, K Michael A; Berman, Nancy E J.

Brain Res Mol Brain Res ; 126(1): 57-66, 2004 Jul 05.

Artículo en Inglés | MEDLINE | ID: mdl-15207916

11.

Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

Callahan, Alfred; Amarenco, Pierre; Goldstein, Larry B; Sillesen, Henrik; Messig, Mike; Samsa, Gregory P; Altafullah, Irfan; Ledbetter, Lucy Y; MacLeod, Mary J; Scott, Russell; Hennerici, Michael; Zivin, Justin A; Welch, K Michael A.

Arch Neurol ; 68(10): 1245-51, 2011 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-21670382

12.

"Ottorino Rossi" Award 2003.

Welch, K Michael A.

Funct Neurol ; 18(3): 119-20, 2003.

Artículo en Inglés | MEDLINE | ID: mdl-14703892

13.

Chronic daily headache: nosology and pathophysiology.

Welch, K Michael A; Goadsby, Peter J.

Curr Opin Neurol ; 15(3): 287-95, 2002 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-12045727

14.

Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out.

Goldstein, Larry B; Amarenco, Pierre; Bogousslavsky, Julien; Callahan, Alfred S; Hennerici, Michael G; Welch, K Michael A; Zivin, Justin; Sillesen, Henrik.

Cerebrovasc Dis ; 18(1): 1-2, 2004.

Artículo en Inglés | MEDLINE | ID: mdl-15159613

Portal de Búsqueda de la BVS Colombia

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: